Ovid Therapeutics Inc.
OVID · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $21 | $28 | $21 | $26 |
| Short-Term Investments | $5 | $10 | $22 | $27 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $0 | $0 | $0 |
| Total Curr. Assets | $29 | $42 | $46 | $56 |
| Property Plant & Equip (Net) | $12 | $13 | $13 | $13 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $21 | $21 | $21 | $21 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $2 | $2 | $2 |
| Total NC Assets | $35 | $35 | $36 | $36 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $64 | $77 | $82 | $92 |
| Liabilities | – | – | – | – |
| Payables | $2 | $4 | $2 | $3 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $1 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $1 | $0 | $0 |
| Total Curr. Liab. | $7 | $9 | $9 | $11 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $12 | $13 | $13 | $13 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $14 | $14 | $15 |
| Total Liabilities | $19 | $22 | $22 | $24 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$331 | -$319 | -$315 | -$304 |
| AOCI | -$0 | -$0 | -$0 | -$0 |
| Other Equity | $0 | -$0 | $0 | -$0 |
| Total Equity | $45 | $56 | $59 | $68 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $64 | $77 | $82 | $92 |
| Net Debt | -$21 | -$28 | -$21 | -$26 |